Ending Specialist Follow-up for Patients With Low-Risk CLL
Posted: 04/24/2024 | By: Kayla Chu

A study published by Brieghel et al in Blood Advances investigated 3-year clinical outcomes among patients with low-risk chronic lymphocytic leukemia (CLL) selected by clinical assessment to end specialized follow-up as compared with patients continuing with specialized follow-up.

Question 1 of 5

Based on the implications of this study, the researchers suggested that ___.

Choose 1